Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: A randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 317, Issue 21, 2017, Pages 2177-2186

  Murphy, Patrick B ^a,b   Rehal, Sunita ^c   Arbane, Gill ^a   Bourke, Stephen ^d,e   Calverley, Peter M A ^f   Crook, Angela M ^c   Dowson, Lee ^g   Duffy, Nicholas ^h   Gibson, G John ⁱ   Hughes, Philip D ^j   Hurst, John R ^c   Lewis, Keir E ^k   Mukherjee, Rahul ^l   Nickol, Annabel ^m   Oscroft, Nicholas ⁿ   Patout, Maxime ^a   Pepperell, Justin ^o   Smith, Ian ⁿ   Stradling, John R ^m   Wedzicha, Jadwiga A ^p   Polkey, Michael I ^p   Elliott, Mark W ^q   Hart, Nicholas ^a,b   more..

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^h UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^k SWANSEA UNIVERSITY   (United Kingdom)

^l UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ PAPWORTH HOSPITAL   (United Kingdom)

^o TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^p ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^q UNIVERSITY OF LEEDS   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT;

ACIDEMIA; ACUTE DISEASE; ADULT; AGE; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD GAS ANALYSIS; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEATH; DISEASE EXACERBATION; FEMALE; FLOW RATE; FORCED EXPIRATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOME OXYGEN THERAPY; HOSPITAL MORTALITY; HOSPITAL READMISSION; HUMAN; HYPERCAPNIA; HYPOVENTILATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONINVASIVE VENTILATION; OUTCOME ASSESSMENT; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY ACIDEMIA; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; UNITED KINGDOM; CLINICAL TRIAL; COMPLICATION; HOME CARE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PHASE 3 CLINICAL TRIAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY INSUFFICIENCY; RISK; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

AGED; COMBINED MODALITY THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HOME CARE SERVICES; HUMANS; HYPERCAPNIA; MALE; MIDDLE AGED; NONINVASIVE VENTILATION; OXYGEN INHALATION THERAPY; PATIENT READMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY INSUFFICIENCY; RISK; TIME FACTORS;

EID: 85020387471     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.4451     Document Type: Article

References (32)

1. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995; 333(13): 817-822.
2. Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet. 1993; 341(8860): 1555-1557.
3. Connors AF Jr, Dawson NV, Thomas C, et al; SUPPORT Investigators (StudytoUnderstand Prognoses and Preferences for Outcomes and Risks of Treatments). Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med. 1996; 154(4 pt 1): 959-967.
4. Murray I, Paterson E, Thain G, Currie GP. Outcomes following non-invasive ventilation for hypercapnic exacerbations of chronic obstructive pulmonary disease. Thorax. 2011; 66(9): 825-826.
5. Chu CM, Chan VL, Lin AW, Wong IW, Leung WS, Lai CK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax. 2004; 59(12): 1020-1025.
6. Suh ES, Mandal S, Harding R, et al. Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD. Thorax. 2015; 70(12): 1123-1130.
7. Nickol AH, Hart N, Hopkinson NS, et al. Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV. Int J Chron Obstruct Pulmon Dis. 2008; 3(3): 453-462.
8. Meecham Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. AmJRespir Crit Care Med. 1995; 152(2): 538-544.
9. Elliott MW, Mulvey DA, Moxham J, Green M, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions. Eur Respir J. 1991; 4(9): 1044-1052.
10. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J. 2005; 25(6): 1025-1031.
11. Clini E, Sturani C, Rossi A, et al.; Rehabilitation and Chronic Care Study Group, Italian Association of Hospital Pulmonologists (AIPO). The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J. 2002; 20(3): 529-538.
12. McEvoy RD, Pierce RJ, Hillman D, et al.; Australian trial of non-invasive Ventilation in Chronic Airflow Limitation (AVCAL) Study Group. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax. 2009; 64(7): 561-566.
13. Windisch W. Noninvasive positive pressure ventilation in COPD. Breathe. 2011; 8(2): 114-123.
14. Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014; 2(9): 698-705.
15. Struik FM, Sprooten RT, Kerstjens HA, et al. Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study. Thorax. 2014; 69(9): 826-834.
16. Altman DG, Bland JM. Treatment allocation by minimisation. BMJ. 2005; 330(7495): 843.
17. Murphy PB, Brignall K, Moxham J, Polkey MI, Davidson AC, Hart N. High pressure versus high intensity noninvasive ventilation in stable hypercapnic chronic obstructive pulmonary disease: a randomized crossover trial. Int J Chron Obstruct Pulmon Dis. 2012; 7: 811-818.
18. National Institute for Health and Clinical Excellence (NICE). Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management [CG101]. London, England: NICE; 2010.
19. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7): 581-586.
20. Ghosh D, Rzehak P, Elliott MW, Windisch W. Validation of the English Severe Respiratory Insufficiency Questionnaire. Eur Respir J. 2012; 40 (2): 408-415.
21. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med. 1991; 85(suppl B): 25-31.
22. Jones PW St George's Respiratory Questionnaire: MCID. COPD. 2005; 2(1): 75-79.
23. Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med. 2012; 31(4): 328-340.
24. Costello R, Deegan P, Fitzpatrick M, McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med. 1997; 102(3): 239-244.
25. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(5 pt 1): 1418-1422.
26. De Backer L, Vos W, Dieriks B, et al. The effects of long-term noninvasive ventilation in hypercapnic COPD patients: a randomized controlled pilot study. Int J Chron Obstruct Pulmon Dis. 2011; 6: 615-624.
27. Gates KL, Howell HA, Nair A, et al. Hypercapnia impairs lung neutrophil function and increases mortality inmurine pseudomonas pneumonia. Am J Respir Cell Mol Biol. 2013; 49(5): 821-828.
28. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002; 359(9302): 204-210.
29. Saatci E, Miller DM, Stell IM, Lee KC, Moxham J. Dynamic dead spacein face masks used with noninvasive ventilators: a lung model study. Eur Respir J. 2004; 23(1): 129-135.
30. Rodway GW, Weaver TE, Mancini C, et al. Evaluation of sham-CPAP asaplaceboin CPAP intervention studies. Sleep. 2010; 33(2): 260-266.
31. Djavadkhani Y, Marshall NS, D'Rozario AL, et al. Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial. Thorax. 2015; 70(3): 265-269.
32. Schwartz SW, Cimino CR, Anderson WM. CPAP or placebo-effect? Sleep. 2012; 35(12): 1585-1586.